Answers are grounded in this paper and cite their sources.
Background: Hypertension remains a leading public health concern in Saudi Arabia, with many patients experiencing challenges in medication adherence, awareness, and blood pressure control. Pharmacists have the potential to play a vital role in improving these outcomes through education and ongoing support. Objective: To assess awareness, medication management practices, and the utilization of pharmacy services among hypertensive patients attending primary healthcare centers (PHCs) in Saudi Arabia. Methods: A descriptive cross-sectional study was conducted among 235 adult Saudi hypertensive patients attending urban and rural PHCs in the Abha region. Data were collected using a structured, self-administered questionnaire developed based on literature and expert input. The questionnaire assessed sociodemographic characteristics, medication adherence, awareness of antihypertensive medications, use of pharmacy services, and self-reported blood pressure control. Data analysis was performed using SPSS version 18. Awareness scores were categorized as poor (<60%) or good (>60%), and associations were tested using the Chi-square test, with a significance threshold set at p < 0.05. Results: The majority of participants (76.6%) demonstrated poor awareness of their antihypertensive medications, while only 23.4% had good awareness. Additionally, 56.2% of patients reported never receiving medication information from a pharmacist. Only 21.3% of patients reported feeling very clear about the purpose of their medications, and 26.4% had received pharmacist-led education on lifestyle modifications. Key factors significantly associated with better awareness included gender (p = .039), marital status (p = .006), education level (p = .032), duration of hypertension (p = .004), and frequency of blood pressure monitoring (p = .049). Conclusion: There is an urgent need to improve hypertension management in primary care by enhancing patient education, addressing barriers to adherence, and expanding the role of pharmacists in chronic disease support.
No takes yet. Share an insight, caveat, or question.
Abdulmohsen Saad Y Al Ahmari (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: